<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Bielefeld-CeBiTec_Project_DateRapeDrugs_Background skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Bielefeld-CeBiTec/Project/DateRapeDrugs/Background</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>iGEM Bielefeld 2015</TITLE></P><DIV class="navbar navbar-default navbar-fixed-top" role="navigation"><DIV class="container"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-ex1-collapse"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse navbar-ex1-collapse"><UL class="nav navbar-nav" style="margin-left: -0.5em"><LI class="menu-item dropdown"><A href="#" class="dropdown-toggle glow" data-toggle="dropdown" id="project">Project </A></LI><LI><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Overview">Overview</A></LI><LI class="menu-item dropdown dropdown-submenu"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Biosensor Design</A></LI><LI class="menu-item "><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/BiosensorDesignMotivation">Motivation</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/CFPS">Cell Free Protein Synthesis</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/PRIA">Plasmid Repressor Interaction Assay</A></LI><LI class="menu-item "><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/Biosafety">Biosafety</A></LI></UL><LI class="menu-item dropdown dropdown-submenu"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Biosensor Targets</A></LI><LI class="menu-item "><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/BiosensorFunctionMotivation">Motivation</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/HeavyMetals">Heavy Metals</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs">Date Rape Drugs</A></LI><LI><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Description">Foundations</A></LI><LI><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/Detection">Output signal</A></LI><LI class="menu-item dropdown"><A class="dropdown-toggle glow" data-toggle="dropdown" href="#" id="results">Results
          </A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results">Overview</A></LI><LI class="menu-item dropdown dropdown-submenu"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Design Evolution</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/CFPS">Cell Free Protein Synthesis</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/PRIA">Plasmid Repressor Interaction Assay</A></LI><LI class="menu-item dropdown dropdown-submenu"><A href="#" class="dropdown-toggle" data-toggle="dropdown">Biosensor Characterization</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/HeavyMetals">Heavy Metals</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/DateRapeDrugs">Date Rape Drugs</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Design">Output Signal Processing</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/it-really-works">ALL-IN-ONE Performance</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Parts">Parts</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/InterlabStudy">Interlab Study</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Achievements">Achievements</A></LI><LI class="menu-item dropdown"><A class="dropdown-toggle glow" data-toggle="dropdown" href="#" id="modeling">Modeling
          </A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Modeling">Overview</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Modeling/CFPS">CFPS Model</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Modeling/Biosensor">Biosensor Model</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Modeling/Application">Model Applications</A></LI><LI class="menu-item dropdown"><A class="dropdown-toggle glow" data-toggle="dropdown" href="#" id="team">Team
          </A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Team">Team Members</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Attributions">Attributions</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/BielefeldUniversity">Bielefeld &amp; University</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Contact">Contact</A></LI><LI class="menu-item dropdown"><A class="dropdown-toggle glow" data-toggle="dropdown" href="#" id="pandp">Human Practices
          </A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Practices">Overview</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Practices/DualUse">Dual Use</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Practices/Scenarios">Future Scenarios</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/StreetScience">Street Science</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/StudentsAcademy">Students Academy</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Practices/PressReview">Press Review</A></LI><LI class="menu-item dropdown"><A class="dropdown-toggle glow" data-toggle="dropdown" href="#" id="notebook">Notebook
          </A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Notebook">Lab Notebook</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Protocols">Protocols</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Media">Media &amp; Buffers</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers">Primers</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Organisms">Organisms</A></LI><LI class="dropdown"><A class="dropdown-toggle glow" data-toggle="dropdown" href="#" id="partners">Partners
          </A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Sponsors">Sponsors</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Partners">Partners</A></LI><LI class="menu-item"><A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Collaborations">Collaborations</A></LI></DIV></DIV></DIV><DIV class="container"><DIV class="row"><DIV class="col-md-12"><DIV class="jumbotron" style="background-image: url(https://static.igem.org/mediawiki/2015/1/19/Bielefeld-CeBiTec_DateRapeDrugs_Jumbotron2.jpeg)"><DIV class="jumbotron-text"><H1 style="margin-bottom: 0px">Date rape drugs</H1><P>Additional information</P></DIV></DIV><DIV><DIV><H1>Date rape drugs - additional information</H1><DIV><H2>Pharmacology and toxicology of GHB/GBL</H2><P>The maximum amount of GHB in the blood plasma is found 20-40 minutes after ingestion. The drug therefore reaches its peak of effect on behavior. About 100 mg/ L may cause euphoria and disinhibition, while 500 mg may have deadly consequences and cause respiratory depression ultimately leading to circulation failure. 1-5 % of the ingested substance are recoverable in urine. The time window of the detection is unfortunately very small (3-10h) (<A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs/Background#BusardoJones2015">Busardò and Jones 2015</A>). This decreases the chance of detecting drug intoxications, because cases are often reported too late. </P><H2>Date rape drugs in numbers</H2><P>While it is commonly assumed that date rape drugs pose a threat to women, recent studies show an increase of intoxication in men. During the years 2000-2007 in the emergency department in Barcelona, 505 cases of GHB intoxication were reported, 68% of which were men. The mean age was 24.7 years. 97% of patients developed symptoms in public places (<A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs/Background#Galicia2011">Galicia et al. 2011</A>). In our area, it was difficult to obtain numbers of cases, due to the lack of studies and the unavailability of data from hospitals because of data protection reasons. According to the helpline at our university in the year 2014, 3 cases of suspected intoxication with date rape drugs were reported by women at our university, while the local police recorded no cases. This is probably due to the small time window in which the detection of the ingestion is possible. Mrs. Frese, who works at the helpline at our university, estimates the dark figure to be a lot higher, because victims are often frightened and wait too long to seek help. “A test strip would be a valuable tool that could effectively prevent crimes.” </P><H2>Consequences of intoxication</H2><P>The consequences of date rape drug intoxication are not only of clinical nature. In an interview with our team, Dr. Jorch, doctor at our local childrens hospital and expert in prevention, explained the dangers of date rape drugs. “Date rape drug intoxication can be a traumatical experience. Not only the possibility of crimes but the loss of control and memory are consequences that victims have to face.” Unfortunately, the detection of date rape drugs intoxication is also a problem in the daily clinical schedule due to the short time frame. “In case of admittance of an unconscious patient, we usually determine the blood alcohol level first, because the victims are often admitted from a party where alcohol consume is likely. If the results are not congruent with the level of consciousness, further tests are scheduled. But until then, several hours might already have passed. The availability of a cheap, reliable and easy to handle test strip would probably increase the number of tests for date rape drugs, because at the moment we need to send samples to a laboratory. The availability of a test strip for other recreational drugs would also be a valuable tool to quickly determine the ingested toxin and avoid the possible consequences.” He points out that crimes are often committed by people close to the victim. Therefore, the likelihood of testing ones beverage is not often given, as it might have been bought by a person the victim trusts. A test strip could not only be a tool in prevention, but also in diagnostics and forensics.</P></DIV><H2>Detection</H2><DIV style="float: left"><P>Screening for date rape drugs is possible in a specific time frame, 3-10 h after intoxication. Common practice is the detection of GHB in a urine sample via gas spectroscopy. Rapid tests have the disadvantage of cross-reaction with ethanol, which is often involved as well in cases of intoxication (<A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs/Background#Franken2015">Franken et al. 2015</A>). These enzymatic assays are therefore not suitable for preventional testing of beverages. A repressor/DNA interaction based test therefore has the advantage of specifity. In addition, our cell extract is robust to certain amounts of ethanol. Our rapid test provides significant advantages against current testing methods. </P><H1>Our sensor</H1><DIV style="float: left"><H2> Catabolism of γ-butyrolactone (GBL) in <I>A. tumefaciens</I></H2><FIGURE style="width: 400px; margin-left: 20px; float: right"><FIGCAPTION> The Blc-Operon and the catabolism of GBL in A. tumefaciens. GHB: γ-hydroxybutyrate; GBL: γ-butyrolactone; SSA: Succinic semialdehyde; SA: Succinate. </FIGCAPTION></FIGURE><P> The plant pathogen <I>Agrobacterium tumefaciens</I> has been widely used in plant research, as it can transform plant cells with the help of the Ti-plasmid (tumor-inducing plasmid). <I>A. tumefaciens</I> is able to utilize the uncommon carbon and energy source γ-butyrolactone (GBL) found in plants. To do this, the bacterium uses the enzymes of the <I>blcABC</I> operon (<A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs/Background#Chai2007">Chai et al. 2007</A>). This operon is localized on the second megaplasmid of <I>A. tumefaciens</I> C58 strain, pAtC58. <I>blcABC</I> expression is controlled by the repressor protein BlcR . When GBL is not present, two dimers of BlcR form a tetramer and inhibit operon expression by binding to an operator sequence localized in front of the operon, thereby hindering the polymerase from transcribing the DNA (Pan et al. 2011, 2013). The inhibition of operon repression was shown to be inducible not only by GBL, but even stronger by GHB (gamma-hydroxybutyrate) and SSA (succinic semialdehyde) (<A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs/Background#Chai2007">Chai et al. 2007</A>). </P></DIV><DIV class="row"><DIV class="col-md-6"><P>Therefore, our sensor is basing on the repressor BlcR under the control of a constitutive promoter, and the binding sequence of the promoter P<SUB>blc</SUB>. The promoter is followed by a 5' untranslated region and controls transcription of sfGFP, which is the output signal. The device can detect both GBL and GHB. </P></DIV><DIV class="col-md-6"><FIGURE style="width: 400px; margin-left: 20px; float: right"><FIGCAPTION> Molecular function of BlcR repression and derepression.</FIGCAPTION></FIGURE></DIV></DIV><DIV style="float: left"><H2>Catabolism of γ-aminobutyric acid (GABA) in <I>B. subtilis </I></H2><FIGURE style="width: 400px; margin-right: 20px; float: left"><FIGCAPTION> Action of GabR as repressor on its own promoter in a negative feedback loop and as activator on the promoter of the gabT operon. </FIGCAPTION></FIGURE><P>The aerobic gram positive bacterium B. subtilis is comprehensively analyzed. It is able to use y-aminobutyric acid (GABA) in the so called GABA-shunt as carbon and nitrogen source. Therefore, it uses the gabTD genes, that are activated by the transcription factor gabR in presence of GABA and pyridoxal 5’-phosphate (PLP). For this activation, gabR binds the gabT promoter. In addition, gabR underlies an autoregulatory mechanism and binds to its own promoter, repressing the transcription of gabR in presence of PLP and GABA (<A href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs/Background#Edaya2013">Edayathumangalam et al. 2013</A>). 
Because of the structural similarity to GHB, we additionally designed a biosensor detecting GABA as a metabolite of the natural GHB pathway. 
</P></DIV></DIV></DIV><DIV class="references"><H2 style="overflow: visible">References</H2><P id="BusardoJones2015"> 
Busardò, Francesco P.; Jones, Alan W. (2015): GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome. In: Current neuropharmacology 13 (1), S. 47–70. DOI: 10.2174/1570159X13666141210215423.
</P><P id="Galicia2011">
Galicia, Miguel; Nogue, Santiago; Miró, Oscar (2011): Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients. In: Emergency medicine journal : EMJ 28 (6), S. 462–466. DOI: 10.1136/emj.2008.068403.
</P><P id="Chai2007">
Chai, Yunrong; Tsai, Ching Sung; Cho, Hongbaek; Winans, Stephen C. (2007): Reconstitution of the biochemical activities of the AttJ repressor and the AttK, AttL, and AttM catabolic enzymes of Agrobacterium tumefaciens. In: Journal of bacteriology 189 (9), S. 3674–3679. DOI: 10.1128/JB.01274-06.</P><P id="Edaya2013">
Edayathumangalam, Raji; Wu, Rui; Garcia, Roman; Wang, Yuguang; Wang, Wei; Kreinbring, Cheryl A. et al. (2013): Crystal structure of Bacillus subtilis GabR, an autorepressor and transcriptional activator of gabT. In: Proceedings of the National Academy of Sciences of the United States of America 110 (44), S. 17820–17825. DOI: 10.1073/pnas.1315887110.</P><P id="Franken2015">
Franken, Linda G.; Andrews, Louise M.; Slooff, Valerie D.; Wildt, Saskia N. de; Koch, Birgit C. P. (2015): Intoxication of a young girl reveals the pitfalls of GHB rapid screening. In: Therapeutic drug monitoring. DOI: 10.1097/FTD.0000000000000244.
</P></DIV><DIV class="row footer"><DIV class="col-md-2 text-center"><A type="button" class="btn btn-default btn-next" href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/DateRapeDrugs"><P>Overview</P></A></DIV><DIV class="col-md-2 col-md-offset-3 text-center"><A type="button" class="btn btn-default btn-next" href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Results/DateRapeDrugs"><P>Results</P></A></DIV><DIV class="col-md-2 col-md-offset-3 text-center"><A type="button" class="btn btn-default btn-next" href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Project/Detection"><P>How do I evaluate the test result?</P></A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>